Controlled arterial hypertension and blood-brain barrier damage in patients with age-related cerebral small vessel disease and cognitive impairments

Dobrynina L.A.; Shamtieva K.V.; Kremneva E.I.; Zabitova M.R.; Gadzhieva Z.Sh.; Krotenkova M.V.

doi:https://doi.org/10.17116/jnevro202212211174

Dobrynina L.A.

Research Center of Neurology

ORCID: 0000-0001-9929-2725

Shamtieva K.V.

Research Center of Neurology

Kremneva E.I.

Research Center of Neurology

Zabitova M.R.

Research Center of Neurology

Gadzhieva Z.Sh.

Research Center of Neurology

Krotenkova M.V.

Research Center of Neurology

Controlled arterial hypertension and blood-brain barrier damage in patients with age-related cerebral small vessel disease and cognitive impairments

Authors:

Dobrynina L.A., Shamtieva K.V., Kremneva E.I., Zabitova M.R., Gadzhieva Z.Sh., Krotenkova M.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11): 74‑79

DOI: 10.17116/jnevro202212211174

Read: 2297 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Dobrynina LA, Shamtieva KV, Kremneva EI, Zabitova MR, Gadzhieva ZSh, Krotenkova MV. Controlled arterial hypertension and blood-brain barrier damage in patients with age-related cerebral small vessel disease and cognitive impairments. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(11):74‑79. (In Russ.)
https://doi.org/10.17116/jnevro202212211174

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate the relationship between blood pressure (BP) profile and blood-brain barrier (BBB) permeability in age-related cerebral microangiopathy (CMA) in patients with- and without controlled arterial hypertension (AH).

MATERIAL AND METHODS

24-hour ambulatory BP monitoring (ABPM), brain MRI, including T1-weighted dynamic contrast images, were performed in 53 patients with CMA (age 60.1±6.8, women 69.8%, controlled hypertension/normal BP 84.8%/15.2%) and 17 healthy volunteers.

RESULTS

ABPM showed good control of AH with most of the assessed parameters associated with the severity of white matter hyperintensity (WMH). The permeability of the BBB in normal-appearing white matter (NAWM) and gray matter in patients with CMA was significantly higher than in the control group and was associated with ABPM parameters. The permeability of the BBB in WMH decreased with an increase in its severity.

CONCLUSION

BBB permeability is a universal mechanism of NAWM and gray matter damage that supports the progression of WMH in CMA patients with controlled AH and without AH. The relationship of increased BBB permeability with slight deviations of ABPM can be explained by common mechanisms of their development due to endothelial dysfunction due to CMA and also points to the utility of more aggressive AH treatment. It is advisable to study the effect of antihypertensive and vascular drugs on BBB permeability with a view to their potential use in CMA.

Keywords:

cerebral small vessel disease

cognitive impairments

arterial hypertension

T1-weighted dynamic contrast-enhanced MRI

blood-brain barrier permeability

Authors:

Dobrynina L.A.

Research Center of Neurology

ORCID: 0000-0001-9929-2725

Shamtieva K.V.

Research Center of Neurology

Kremneva E.I.

Research Center of Neurology

Zabitova M.R.

Research Center of Neurology

Gadzhieva Z.Sh.

Research Center of Neurology

Krotenkova M.V.

Research Center of Neurology

Received:

02.09.2022

Accepted:

11.09.2022

Close metadata

References:

Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689-701. https://doi.org/10.1016/S1474-4422(10)70104-6
Jokinen H, Koikkalainen J, Laakso HM, et al. Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline. Stroke. 2020;51(1):170-178. https://doi.org/10.1161/STROKEAHA.119.026170
Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12(5):483-497. https://doi.org/10.1016/S1474-4422(13)70060-7
Dufouil C, de Kersaint-Gilly A, Besançon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology. 2001;56(7):921-926. https://doi.org/10.1212/wnl.56.7.921
Parfenov VA. Discirkulyatornaya encefalopatiya i sosudistye kognitivnye rasstrojstva. M.: IMA-Press; 2017;123. (In Russ.).
Kalashnikova LA, Gulevskaya TS, Dobrynina LA. Actual problems of brain pathology in cerebral microangiopathy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(2):90-99. (In Russ.). https://doi.org/10.17116/jnevro20181182190-99
Koltover AN, Lyudkovskaya IG, Gulevskaya TS, et al. Gipertonicheskaya angioencefalopatiya v patomorfologicheskom aspekte. Zhurnal nevropatologii i psihiatrii im. S.S. Korsakova. 1984;84(7):1016-1020. (In Russ.).
McAleese KE, Alafuzoff I, Charidimou A, et al. Post-mortem assessment in vascular dementia: advances and aspirations. BMC Med. 2016;14(1):129. https://doi.org/10.1186/s12916-016-0676-5
Arima H, Chalmers J. PROGRESS: Prevention of Recurrent Stroke. J Clin Hypertens (Greenwich). 2011;13(9):693-702. https://doi.org/10.1111/j.1751-7176.2011.00530.x
Ma Y, Song A, Viswanathan A, et al. Blood Pressure Variability and Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts. Stroke. 2020;51(1):82-89. https://doi.org/10.1161/STROKEAHA.119.026739
Williamson JD, Pajewski NM, et al. SPRINT MIND Investigators for the SPRINT Research Group, Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553-561. https://doi.org/10.1001/jama.2018.21442
Mamo JCL, Lam V, Giles C, et al. Antihypertensive agents do not prevent blood-brain barrier dysfunction and cognitive deficits in dietary-induced obese mice. Int J Obes (Lond). 2017;41(6):926-934. https://doi.org/10.1038/ijo.2017.57
Schreiber S, Bueche CZ, Garz C, Braun H. Blood brain barrier breakdown as the starting point of cerebral small vessel disease? — New insights from a rat model. Exp Transl Stroke Med. 2013;5(1):4-10. https://doi.org/10.1186/2040-7378-5-4
Wardlaw JM, Doubal FN, Valdes-Hernandez M, et al. Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. Stroke. 2013;44(2):525-527. https://doi.org/10.1161/STROKEAHA.112.669994
Iadecola C, Yaffe K, Biller J, et al. Impact of Hypertension on Cognitive Function: Scientific Statement From American Heart Association. Hypertension. 2016;68(6):67-94. https://doi.org/10.1161/HYP.0000000000000053
Gannushkina IV, Lebedeva NV. Gipertonicheskaya encefalopatiya. M.: Medicina; 1987;224. (In Russ.).
Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol. 2013;304(12):H1598-614. https://doi.org/10.1152/ajpheart.00490.2012
Hazama AF, Amano S, Ozaki T. Pathological changes of cerebral vessel endothelial cells in spontaneously hypertensive rats, with special reference to the role of these cells in the development of hypertensive cerebrovascular lesions. Adv Neurol. 1978;20:359-369.
Thrippleton MJ, Backes WH, Sourbron S, et al. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations. Alzheimers Dement. 2019;15(6):840-858. https://doi.org/10.1016/j.jalz.2019.01.013
Dobrynina LA, Shabalina AA, Zabitova MR, et al. Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease. Brain Sci. 2019;9(10):266-270. https://doi.org/10.3390/brainsci9100266
Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry. 2010;81(2):192-197. https://doi.org/10.1136/jnnp.2009.172072
Dobrynina LA, Gnedovskaya EV, Sergeeva AN, et al. Changes in the MRI brain picture associated with newly diagnosed asymptomatic arterial hypertension. Annaly klinicheskoj i eksperimental’noj nevrologii. 2016;10(3):25-32. (In Russ.).
Wardlaw JM. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. Alzheimer’s & Dementia. 2017;13(6):634-643. https://doi.org/10.1016/j.jalz.2016.09.006
Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270-279. https://doi.org/10.1016/j.jalz.2011.03.008
Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10(3):143-155. https://doi.org/10.1038/nrcardio.2013.1
Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Rus J Cardiol. 2020;25(3):3786. (In Russ.). https://doi.org/10.15829/1560-4071-2020-3-3786
Dobrynina LA, Shamtieva KV, Kremneva EI, et al. Daily profile of arterial pressure and brain microstructural changes in patients with hypertension-related cerebral small vessel disease. Annals of clinical and experimental neurology. 2019;13(1):36-46. (In Russ.). https://doi.org/10.25692/ACEN.2019.1.5
Fazekas F, Chawluk JB, Alavi A, et al. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149(2):351-356. https://doi.org/10.2214/ajr.149.2.351
Li Y, Chen H, He L, et al. Hemodynamic assessments of venous pulsatile tinnitus using 4D-flow MRI. Neurology. 2018;91(6):586-593. https://doi.org/10.1212/WNL.0000000000005948
Rajani RM, Quick S, Ruigrok SR, et al. Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats. Sci Transl Med. 2018;10(448):eaam9507. https://doi.org/10.1126/scitranslmed.aam9507
Huisa BN, Caprihan A, Thompson J, et al. Long-Term Blood-Brain Barrier Permeability Changes in Binswanger Disease. Stroke. 2015;46(9):2413-2418. https://doi.org/10.1161/STROKEAHA.115.009589
Li Y, Li M, Zhang X, et al. Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden. J Neurol. 2017;264(7):1474-1481. https://doi.org/10.1007/s00415-017-8550-8
Tryambake D, He J, Firbank MJ, et al. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension. Hypertension. 2013;61(6):1309-1315. https://doi.org/10.1161/HYPERTENSIONAHA.112.200972
Mancia G, Kjeldsen SE, Zappe DH, et al. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. Eur Heart J. 2016;37(12):955-964. https://doi.org/10.1093/eurheartj/ehv633
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269-1324. https://doi.org/10.1161/HYP.0000000000000066
Croall ID, Tozer DJ, Moynihan B, et al. Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial. JAMA Neurol. 2018;75(6):720-727. https://doi.org/10.1001/jamaneurol.2017.5153
Dobrynina LA, Shabalina AA, Shamtieva KV, et al. Salt sensitivity and osmotic fragility are newly specified risk factors for age-related cerebral microangiopathy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2021;121(3):77-85. (In Russ.). https://doi.org/10.17116/jnevro202112103177
Dobrynina LA, Shabalina AA, Shamtieva KV, et al. The Predictive Value of Salt Sensitivity and Osmotic Fragility in the Development of Cerebral Small Vessel Disease. Int J Mol Sci. 2020;21(6):2036. https://doi.org/10.3390/ijms21062036
Ihara M, Yamamoto Y. Emerging Evidence for Pathogenesis of Sporadic Cerebral Small Vessel Disease. Stroke. 2016;47(2):554-560. https://doi.org/10.1161/STROKEAHA.115.009627